DGX vs LEXXW · P/E 22, rev $5.94B vs rev $705.9K
Quest Diagnostics Incorporated (DGX) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the DGX and LEXXW stock pages for the full models.
Not investment advice.